Kfar Saba, Israel (ots/PRNewswire) - Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint CartiHeal Ltd, developer of implants for the treatment of cartilage and ...
Kfar Saba, Israel (ots/PRNewswire) - According to a Two-Year Randomized and Controlled Multinational IDE Study CartiHeal Ltd, developer of Agili-C(TM), a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, which was granted Breakthrough Device Designation by the FDA last ...
Kfar Saba, Israel (ots/PRNewswire) - CartiHeal, developer of Agili-C(TM), a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the first implantation of the Agili-C(TM) implant, as part of Investigational Device Exemption (IDE) clinical study by Dr. ...
Kfar Saba, Israel (ots/PRNewswire) - The procedure was performed by Joseph M. Berman, MD, an orthopedic surgeon at Arlington Orthopedics Associates (AOA), Arlington, TX - CartiHeal, developer of Agili-C(TM), a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the first implantation of the Agili-C(TM) ...
Kfar Saba, Israel (ots/PRNewswire) - Two patients were enrolled and operated on by sports medicine surgeon Andreas Gomoll, MD CartiHeal, developer of Agili-C(TM), a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the successful enrollment and ...
Kfar Saba, Israel (ots/PRNewswire) - Four patients enrolled and operated on by sports medicine surgeon Dr. Seth L. Sherman, MD Seth L. Sherman, MD, a sports medicine orthopaedic surgeon at Missouri Orthopaedic Institute, recently became one of the first American surgeons to enroll patients in a clinical research ...
